173 related articles for article (PubMed ID: 27036617)
1. A high-throughput screening-compatible homogeneous time-resolved fluorescence assay measuring the glycohydrolase activity of human poly(ADP-ribose) glycohydrolase.
Stowell AI; James DI; Waddell ID; Bennett N; Truman C; Hardern IM; Ogilvie DJ
Anal Biochem; 2016 Jun; 503():58-64. PubMed ID: 27036617
[TBL] [Abstract][Full Text] [Related]
2. A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): application to inhibitor identification and evaluation.
Putt KS; Hergenrother PJ
Anal Biochem; 2004 Oct; 333(2):256-64. PubMed ID: 15450800
[TBL] [Abstract][Full Text] [Related]
3. Discovery and structure-activity relationships of modified salicylanilides as cell permeable inhibitors of poly(ADP-ribose) glycohydrolase (PARG).
Steffen JD; Coyle DL; Damodaran K; Beroza P; Jacobson MK
J Med Chem; 2011 Aug; 54(15):5403-13. PubMed ID: 21692479
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADP-ribose).
Okita N; Ashizawa D; Ohta R; Abe H; Tanuma S
Biochem Biophys Res Commun; 2010 Feb; 392(4):485-9. PubMed ID: 20079708
[TBL] [Abstract][Full Text] [Related]
5. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase.
Kim IK; Stegeman RA; Brosey CA; Ellenberger T
J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
Feng X; Koh DW
Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
[TBL] [Abstract][Full Text] [Related]
7. Selective small molecule inhibition of poly(ADP-ribose) glycohydrolase (PARG).
Finch KE; Knezevic CE; Nottbohm AC; Partlow KC; Hergenrother PJ
ACS Chem Biol; 2012 Mar; 7(3):563-70. PubMed ID: 22220926
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of phenolic hydrazide hydrazones as potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors.
Islam R; Koizumi F; Kodera Y; Inoue K; Okawara T; Masutani M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3802-6. PubMed ID: 25042255
[TBL] [Abstract][Full Text] [Related]
9. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.
Slade D; Dunstan MS; Barkauskaite E; Weston R; Lafite P; Dixon N; Ahel M; Leys D; Ahel I
Nature; 2011 Sep; 477(7366):616-20. PubMed ID: 21892188
[TBL] [Abstract][Full Text] [Related]
10. Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.
Tanuma SI; Shibui Y; Oyama T; Uchiumi F; Abe H
Biochem Pharmacol; 2019 Sep; 167():163-172. PubMed ID: 31176615
[TBL] [Abstract][Full Text] [Related]
11. Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain.
Poitras MF; Koh DW; Yu SW; Andrabi SA; Mandir AS; Poirier GG; Dawson VL; Dawson TM
Neuroscience; 2007 Aug; 148(1):198-211. PubMed ID: 17640816
[TBL] [Abstract][Full Text] [Related]
12. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase.
Tanuma S; Sato A; Oyama T; Yoshimori A; Abe H; Uchiumi F
Curr Protein Pept Sci; 2016; 17(7):668-682. PubMed ID: 27817743
[TBL] [Abstract][Full Text] [Related]
13. Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase.
Gravells P; Grant E; Smith KM; James DI; Bryant HE
DNA Repair (Amst); 2017 Apr; 52():81-91. PubMed ID: 28254358
[TBL] [Abstract][Full Text] [Related]
14. Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells.
Frizzell KM; Gamble MJ; Berrocal JG; Zhang T; Krishnakumar R; Cen Y; Sauve AA; Kraus WL
J Biol Chem; 2009 Dec; 284(49):33926-38. PubMed ID: 19812418
[TBL] [Abstract][Full Text] [Related]
15. Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activities.
Barkauskaite E; Brassington A; Tan ES; Warwicker J; Dunstan MS; Banos B; Lafite P; Ahel M; Mitchison TJ; Ahel I; Leys D
Nat Commun; 2013; 4():2164. PubMed ID: 23917065
[TBL] [Abstract][Full Text] [Related]
16. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.
Brosey CA; Houl JH; Katsonis P; Balapiti-Modarage LPF; Bommagani S; Arvai A; Moiani D; Bacolla A; Link T; Warden LS; Lichtarge O; Jones DE; Ahmed Z; Tainer JA
Prog Biophys Mol Biol; 2021 Aug; 163():171-186. PubMed ID: 33636189
[TBL] [Abstract][Full Text] [Related]
17. Expression of poly(ADP-ribose) glycohydrolase in wild-type and PARG-110 knock-out retina.
Sahaboglu A; Bolz S; Löwenheim H; Paquet-Durand F
Adv Exp Med Biol; 2014; 801():463-9. PubMed ID: 24664732
[TBL] [Abstract][Full Text] [Related]
18. An assay to measure poly(ADP ribose) glycohydrolase (PARG) activity in cells.
James DI; Durant S; Eckersley K; Fairweather E; Griffiths LA; Hamilton N; Kelly P; O'Connor M; Shea K; Waddell ID; Ogilvie DJ
F1000Res; 2016; 5():736. PubMed ID: 27610220
[TBL] [Abstract][Full Text] [Related]
19. PARG Inhibitors and Functional PARG Inhibition Models.
Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M
Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) - Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy.
Harrision D; Gravells P; Thompson R; Bryant HE
Front Mol Biosci; 2020; 7():191. PubMed ID: 33005627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]